Effect of atorvastatin on tumor growth and metastasis in a breast cancer cell xenograft model and its mechanism

Frontiers of Medicine in China

Volumn 3, Issue 4, 2009, Pages 443-446

  Liu, Liu ^a   Ning, Yaogui ^a   Chen, Chen ^a   Wang, Daowen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Atorvastatin; CYP2J2; Metastasis; Xenograft tumor

Indexed keywords

EID: 73349093394     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-009-0079-5     Document Type: Article

References (22)

1. R. E. Harris G. A. Alshafie H. Abou-Issa K. Seibert 2000 Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor Cancer Res 60 8 2101 2103 1:CAS:528:DC%2BD3cXivVaks7Y%3D 10786667
2. A. Jemal T. Murray A. Samuels A. Ghafoor E. Ward M. J. Thun 2003 Cancer statistics, 2003 CA Cancer J Clin 53 1 5 26 10.3322/canjclin.53.1.5 12568441
3. V. G. Athyros A. I. Kakafika K. Tziomalos A. Karagiannis D. P. Mikhailidis 2009 Pleiotropic effects of statins-clinical evidence Curr Pharm Des 15 5 479 489 10.2174/138161209787315729 1:CAS:528:DC%2BD1MXkvVSnt7g%3D 19199976
4. J. Kuoppala A. Lamminpää E. Pukkala 2008 Statins and cancer: A systematic review and meta-analysis Eur J Cancer 44 15 2122 2132 10.1016/j.ejca.2008.06.025 1:CAS:528:DC%2BD1cXht1Sis73M 18707867
5. J. G. Jiang C. L. Chen J. W. Card S. Yang J. X. Chen X. N. Fu Y. G. Ning X. Xiao D. C. Zeldin D. W. Wang 2005 Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors Cancer Res 65 11 4707 4715 10.1158/0008-5472.CAN-04-4173 1:CAS:528:DC%2BD2MXks1Ohtbs%3D 15930289 (Pubitemid 40740807)
6. J. G. Jiang Y. G. Ning C. Chen D. Ma Z. J. Liu S. Yang J. Zhou X. Xiao X. A. Zhang M. L. Edin J. W. Card J. Wang D. C. Zeldin D. W. Wang 2007 Cytochrome p450 epoxygenase promotes human cancer metastasis Cancer Res 67 14 6665 6674 10.1158/0008-5472.CAN-06-3643 1:CAS:528:DC%2BD2sXnslOjtbw%3D 17638876
7. R. H. Knopp 1999 Drug treatment of lipid disorders N Engl J Med 341 7 498 511 10.1056/NEJM199908123410707 1:STN:280:DyaK1MzltlGjtQ%3D%3D 10441607 (Pubitemid 29372891)
8. J. Davignon 2004 Beneficial cardiovascular pleiotropic effects of statins Circulation 109 23Suppl1 III39 43 15198965
9. J. K. Liao 2005 Effects of statins on 3-Hydroxy-3-methyglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol Am J Cardiol 96 [5A] 24F 33F 10.1016/j.amjcard.2005.06.009 1:CAS:528:DC%2BD2MXhtVGgtr7M 16126020 (Pubitemid 41207730)
10. O. Adam H. R. Neuberger M. Böhm U. Laufs 2008 Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Circulation 118 12 1285 1293 10.1161/CIRCULATIONAHA.107.760892 18794401
11. A. Hall 1998 Rho GTPase and the actin cytoskeleton Science 279 5350 509 514 10.1126/science.279.5350.509 1:CAS:528:DyaK1cXotVKrsQ%3D%3D 9438836 (Pubitemid 28067271)
12. E. Sahai C. J. Marshall 2002 Rho-GTPases and cancer Nat Rev Cancer 2 2 133 142 10.1038/nrc725 12635176
13. Garwood E R, Kumar A S, Baehner F L, Moore D H, Au A, Hylton N, Flowers C I, Garber J, Lesnikoski B A, Hwang E S, Olopade O, Port E R, Campbell M, Esserman L J. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat, 2009Aug29. [Epub ahead of print]
14. S. Kang E. S. Kim A. Moon 2009 Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras Oncol Rep 21 5 1317 1322 19360310
15. F. Mannello G. A. Tonti 2009 Statins and breast cancer: may matrix metalloproteinase be the missing link Cancer Invest 27 4 466 470 10.1080/07357900802491444 1:CAS:528:DC%2BD1MXkt1yisrg%3D 19219650
16. C. A. Sánchez E. Rodríguez E. Varela E. Zapata A. Páez F. A. Massó L. F. Montaño R. Lóopez-Marure 2008 Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress Cancer Invest 26 7 698 707 10.1080/07357900701874658 18608208
17. G. Herrero-Martin A. López-Rivas 2008 Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins FEBS Lett 582 17 2589 2594 10.1016/j.febslet.2008.06.034 1:CAS:528:DC%2BD1cXosVOls70%3D 18582466
18. S. Borgquist S. Djerbi F. Pontén L. Anagnostaki M. Goldman A. Gaber J. Manjer G. Landberg K. Jirström 2008 HMG-oA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors Int J Cancer 123 5 1146 1153 10.1002/ijc.23597 1:CAS:528:DC%2BD1cXhtVSrsLnO 18528862
19. M. J. Campbell L. J. Esserman Y. Zhou M. Shoemaker M. Lobo E. Borman F. Baehner A. S. Kumar K. Adduci C. Marx E. F. Petricoin L. A. Liotta M. Winters S. Benz C. C. Benz 2006 Breast cancer growth prevention by statins Cancer Res 66 17 8707 8714 10.1158/0008-5472.CAN-05-4061 1:CAS:528:DC%2BD28XovF2hsrY%3D 16951186 (Pubitemid 44449187)
20. M. Koyuturk M. Ersoz N. Altiok 2007 Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signaling through JNK Cancer Lett 250 2 220 228 10.1016/j.canlet.2006. 10.009 1:CAS:528:DC%2BD2sXjvFGqtbw%3D 17125918 (Pubitemid 46529446)
21. C. Denoyelle P. Albanese G. Uzan L. Hong J. P. Vannier J. Soria C. Soria 2003 Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells Cell Signal 15 3 327 338 10.1016/S0898-6568(02)00124-9 1:CAS:528: DC%2BD3sXivVKgsQ%3D%3D 12531431 (Pubitemid 36071677)
22. D. C. Zeldin 2001 Epoxygenase pathways of arachidonic acid metabolism J Biol Chem 276 39 36059 36062 10.1074/jbc.R100030200 1:CAS:528: DC%2BD3MXnt1yku7o%3D 11451964